Literature DB >> 1749365

Cerebrospinal fluid amino acids in relation to neurological status in experimental portal-systemic encephalopathy.

G Therrien1, R F Butterworth.   

Abstract

Using an indwelling cisterna magna catheter technique, serial CSF samples were analyzed for amino acid content in rats at various stages of portal-systemic encephalopathy resulting from ammonium acetate administration following portacaval anastomosis. Anastomosis alone resulted in increased CSF concentrations of glutamine, tyrosine, phenylalanine, glutamate and alanine. GABA levels, on the other hand were not significantly changed. Onset of severe neurological symptoms following ammonium acetate administration resulted in selectively increased CSF alanine. Other amino acids were not further increased at severe stages of encephalopathy. Increased CSF alanine probably results from increased glutamine transamination in the brains of portacaval shunted rats.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1749365     DOI: 10.1007/bf00999904

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  19 in total

1.  Portacaval shunt in the rat.

Authors:  S H LEE; B FISHER
Journal:  Surgery       Date:  1961-10       Impact factor: 3.982

2.  Hepatic encephalopathy: lack of changes of gamma-aminobutyric acid content in plasma and cerebrospinal fluid.

Authors:  F Moroni; O Riggio; V Carlà; V Festuccia; F Ghinelli; I R Marino; M Merli; L Natali; G Pedretti; F Fiaccadori
Journal:  Hepatology       Date:  1987 Sep-Oct       Impact factor: 17.425

3.  Brain cortical amino acids measured by intracerebral dialysis in portacaval shunted rats.

Authors:  U Tossman; A Delin; L S Eriksson; U Ungerstedt
Journal:  Neurochem Res       Date:  1987-03       Impact factor: 3.996

4.  Effect of ammonia on brain serotonin metabolism in relation to function in the portacaval shunted rat.

Authors:  M Bergeron; M S Swain; T A Reader; L Grondin; R F Butterworth
Journal:  J Neurochem       Date:  1990-07       Impact factor: 5.372

5.  Affinities and densities of high-affinity [3H]muscimol (GABA-A) binding sites and of central benzodiazepine receptors are unchanged in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy.

Authors:  R F Butterworth; J Lavoie; J F Giguère; G Pomier-Layrargues
Journal:  Hepatology       Date:  1988 Sep-Oct       Impact factor: 17.425

6.  Portacaval anastomosis: brain and plasma metabolite abnormalities and the effect of nutritional therapy.

Authors:  A M Mans; J F Biebuyck; D W Davis; R A Hawkins
Journal:  J Neurochem       Date:  1984-09       Impact factor: 5.372

7.  Ammonia and related amino acids in the pathogenesis of brain edema in acute ischemic liver failure in rats.

Authors:  M Swain; R F Butterworth; A T Blei
Journal:  Hepatology       Date:  1992-03       Impact factor: 17.425

8.  Amino acid changes in regions of the CNS in relation to function in experimental portal-systemic encephalopathy.

Authors:  J F Giguère; R F Butterworth
Journal:  Neurochem Res       Date:  1984-09       Impact factor: 3.996

9.  Aromatic and branched-chain amino acids in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy.

Authors:  M Bergeron; G P Layrargues; R F Butterworth
Journal:  Metab Brain Dis       Date:  1989-09       Impact factor: 3.584

10.  Regional differences in the capacity for ammonia removal by brain following portocaval anastomosis.

Authors:  R F Butterworth; G Girard; J F Giguère
Journal:  J Neurochem       Date:  1988-08       Impact factor: 5.372

View more
  10 in total

1.  Guanosine Exerts Neuroprotective Effect in an Experimental Model of Acute Ammonia Intoxication.

Authors:  G F Cittolin-Santos; A M de Assis; P A Guazzelli; L G Paniz; J S da Silva; M E Calcagnotto; G Hansel; K C Zenki; E Kalinine; M M Duarte; D O Souza
Journal:  Mol Neurobiol       Date:  2016-04-06       Impact factor: 5.590

Review 2.  Neuronal nitric oxide synthase and Hepatic Encephalopathy.

Authors:  V L Rao; R F Butterworth
Journal:  Metab Brain Dis       Date:  1998-09       Impact factor: 3.584

Review 3.  Is ammonia a pathogenetic factor in Alzheimer's disease?

Authors:  N Seiler
Journal:  Neurochem Res       Date:  1993-03       Impact factor: 3.996

4.  Tissue-specific alterations of binding sites for peripheral-type benzodiazepine receptor ligand [3H]PK11195 in rats following portacaval anastomosis.

Authors:  V L Rao; R Audet; G Therrien; R F Butterworth
Journal:  Dig Dis Sci       Date:  1994-05       Impact factor: 3.199

Review 5.  Effects of hyperammonemia and liver failure on glutamatergic neurotransmission.

Authors:  Pilar Monfort; María-Dolores Muñoz; Amina ElAyadi; Elena Kosenko; Vicente Felipo
Journal:  Metab Brain Dis       Date:  2002-12       Impact factor: 3.584

6.  Effect of probenecid on 5-hydroxyindoleacetic acid in cisternal cerebrospinal fluid of rats with portacaval anastomosis.

Authors:  M Bergeron; M S Swain; E Molina-Holgado; T A Reader; R F Butterworth
Journal:  Neurochem Res       Date:  1995-08       Impact factor: 3.996

7.  L-ornithine-L-aspartate in experimental portal-systemic encephalopathy: therapeutic efficacy and mechanism of action.

Authors:  C Rose; A Michalak; P Pannunzio; G Therrien; G Quack; G Kircheis; R F Butterworth
Journal:  Metab Brain Dis       Date:  1998-06       Impact factor: 3.584

8.  L-Tyrosine availability affects basal and stimulated catecholamine indices in prefrontal cortex and striatum of the rat.

Authors:  Zachary D Brodnik; Manda Double; Rodrigo A España; George E Jaskiw
Journal:  Neuropharmacology       Date:  2017-05-29       Impact factor: 5.250

9.  Increased cerebrospinal fluid lactate reflects deterioration of neurological status in experimental portal-systemic encephalopathy.

Authors:  G Therrien; J F Giguère; R F Butterworth
Journal:  Metab Brain Dis       Date:  1991-12       Impact factor: 3.584

Review 10.  Mechanisms of ammonia-induced astrocyte swelling.

Authors:  M D Norenberg; K V Rama Rao; A R Jayakumar
Journal:  Metab Brain Dis       Date:  2005-12       Impact factor: 3.655

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.